Please find below articles from Serbian authors and co-authors that were published in the European Journal of Neurology.

The Rebuplic of Serbia is situaded on the Balkan Penisula and is inhabited with more than 7,000,000 people. With its geoghrafical, pollitycal and cultural position Serbia always united East and West. Giving its history along the centuries - long shape and turbulent past resulting in constant migration of population, Serbia became a multiethic, multicultural and multiconfessional society.

eter Van den Bergh (PVdB): Peripheral neuropathies are common neurological disorders. In the annual EAN congresses, they are an important topic which the Scientific Panel Neuropathies strives to integrate in the scientific and in the educational Program. I would like to introduce the Peripheral Nerve Society (PNS) of which you are the president to the EANpages readership. Can you please explain what the PNS stands for and what its objectives and aims are to the readers of the EANpages? Mary Reilly (MR): The Peripheral Nerve Society (PNS) is an international organisation of physicians and scientists working together to develop and provide the best treatments for people who have peripheral nerve diseases.

For July 2017, we have selected: Fernandez HH, Factor SA, Hauser RA, et al. Randomized controlled trial of deutetrabenazine for tardive dyskinesia. Neurology 2017;88:2003-2010. Tardive dyskinesia (TD) is a relatively frequent complication of antipsychotic treatment. TD can be observed in any part of the body, can be very disabling, and often persists even after stopping the causative medication.

European Neurology has lost one of its great pioneers: Franz Gerstenbrand, emeritus Professor of Neurology at Innsbruck University, Past President of the EFNS and Honorary Member of the EAN passed away on June 30, 2017 at the age of 92.

Don't miss the opportunity to apply for the EAN Research Fellowship until August 31, 2017.

The new CME article July 2017: “Lasting improvement of medication-overuse headache after brief intervention – a long-term follow-up in primary care” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer the questions!… Continue Reading

Chairpersons:
Bernard Uitdehaag, Guenther Deuschl, Paul Boon
during the Highlight session the most prominent topics of the congress were given special recognition: Stroke
Veerle De Herdt, , Belgium Multiple Sclerosis
Rogier Q. Hintzen, Rotterdam, The Netherlands Degenerative disorders including dementia… Continue Reading

ESO/EAN symposium 7: uncommon cerebrovascular diseases Chairpersons:
Stefan Engelter, Basel, Switzerland
C.J.M. (Karin) Klijn, AMERSFOORT, The Netherlands Reversible cerebral vasoconstriction syndrome: how to recognise it?
Anne Ducros, Montpellier, France Cervical artery dissection: where are we now?
Stefan Engelter, Basel, Switzerland… Continue Reading

CME TOPICAL SYMPOSIUM: Spinal muscular atrophy Chairperson
Ulrike Schara, Essen, Germany
Enrico Bertini, Roma, Italy Diagnosis of spinal muscular atrophy
W.Ludo Van Der Pol, Utrecht, The Netherlands Clinical aspects of spinal muscular atrophy
Ulrike Schara, Essen, Germany Therapy and management… Continue Reading

The third Women in Neurology Session: is the landscape really changing with respect to the gender gap? The “Challenges in for Women in Neurology” lunch session took place for the third time at EAN 2017 and featured three successful practitioners… Continue Reading

ILAE-CEA/EAN: Recent and upcoming new drugs and devices for the treatment of epilepsy CHAIRPERSONS: Meir Bialer, JERUSALEM, ISRAEL Paul Boon, GHENT, BELGIUM 25 years new anti-epileptic drugs – did they make a difference?
Eugen Trinka, SALZBURG, AUSTRIA New anti-epileptic drugs… Continue Reading